IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q2 2023 Holdings

Filed 2023-07-24 | 7 holdings | $95.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$34.9M3,510,22836.6%
Ventyx Biosciences Inc(VTYX)COM92332V107$24.5M746,37025.7%
Jasper Therapeutics IncCOM471871103$11.7M8,519,64812.3%
Hillevax IncCOM43157M102$9.6M558,92310.1%
Talaris Therapeutics IncCOM87410C104$8.9M2,932,6069.4%
Elevation Oncology IncCOM28623U101$3.6M2,370,1423.8%
Kezar Life Sciences IncCOM49372L100$2.0M828,7112.1%